[Antiemetic and antinauseant effect of alizapride in patients subjected to antiblastic infusion chemotherapy in a day-hospital regime].
A study about alizapride in out patients with nausea and vomiting during infusional antiblastic chemotherapy.
Cicchetti
F
F
Viganò
P
P
Borghi
C M
CM
Franzini
A
A
Alfano
G
G
Antolini
C
C
D000368:Aged; D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy*; D011759:Pyrrolidines / Q000627:therapeutic use*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy*
D000932:Antiemetics; D000970:Antineoplastic Agents; D011759:Pyrrolidines; C033968:alizapride
Studio dell'azione antiemetica e antinausea dell'alizapride nei pazienti sottoposti a chemioterapia antiblastica infusionale in regime di day-hospital.